Arrhythmias & electrophysiologyCohort study

New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry

Eur Heart JPublished

  • Prospective observational registry study
  • international (45 countries)
  • longitudinal

Authors' conclusion

Among CCS patients, NOAF is common and is strongly associated with worse outcomes.

Study context

Population
Chronic coronary syndromes (CCS) outpatients without previously reported AF at baseline (CLARIFY registry)
Participants
29,001 outpatients
Exposure
New-onset AF vs sinus rhythm throughout
Outcome
Incidence, predictors and impact on cardiovascular (CV) outcomes of NOAF
Follow-up
5-year follow-up

Main finding

As reported in the abstract

Incidence of NOAF

Incidence rate of new-onset atrial fibrillation (NOAF) per 100 patient-years

1.12 (95% CI 1.06-1.18)

Cumulative incidence at 5 years

5.0%

Observational data: associations, not effects.

Further findings

Outcomeadjusted HR (95% CI)
CV outcomes with NOAF — NOAF vs Sinus rhythm · CV death, non-fatal MI or non-fatal stroke2.01 (1.61–2.52)
CV outcomes with NOAF — NOAF vs Sinus rhythm · CV death2.61 (2.04–3.34)
CV outcomes with NOAF — NOAF vs Sinus rhythm · non-fatal MI1.64 (1.07–2.50)
CV outcomes with NOAF — NOAF vs Sinus rhythm · all-cause death2.27 (1.85–2.78)
CV outcomes with NOAF — NOAF vs Sinus rhythm · hospitalization for HF8.44 (7.05–10.10)

Independent predictors of NOAF

Increasing age, increasing BMI, low eGFR, Caucasian ethnicity, alcohol intake and low LVEF predicted NOAF; high TG associated with lower incidence

Safety

Outcomeadjusted HR (95% CI)
Major bleeding4.46 (2.85–6.99)

Original publication

New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry. Eur Heart J. Published 27 August 2023. doi:10.1093/eurheartj/ehad556

Summarised from the published abstract; every number is checked against it